Drawing for POLYCOL

USPTO serial 88141304

POLYCOL

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MEYERS, MORGAN LAURA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with POLYCOL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey K. Mills

Jeffrey K. Mills MEDLER FERRO WOODHOUSE & MILLS PLLC8201 GREENSBORO DRIVE, SUITE 1060MCLEAN, VA 22102UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Amino acids for medical or veterinary purposes; Amino acids for medical purposes; Amino acids for veterinary purposes; Anaesthetics; Analgesics; Biological preparations for the treatment of cancer; Biological preparations for the treatment of ocular disorders or diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for ocular disorders or diseases; Collagen for medical purposes; Diagnostic agents, preparations and substances for medical purposes; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for veterinary purposes; Medicinal preparations for ocular disorders or diseases; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Veterinary diagnostic reagentsACTIVE—
010Anesthetic delivery apparatus; Medical apparatus and instruments for use in ocular disorders or disease procedures; Surgical implants comprised of artificial materials; Surgical implants comprising artificial material; Apparatus for the regeneration of stem cells for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 21, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 20, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 20, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 19, 2021EX5GSOU EXTENSION 5 GRANTED—
Nov 19, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 12, 2021EXT5SOU EXTENSION 5 FILED—
Nov 12, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 14, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 12, 2021EX4GSOU EXTENSION 4 GRANTED—
May 12, 2021EXT4SOU EXTENSION 4 FILED—
May 12, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 14, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 12, 2020EX3GSOU EXTENSION 3 GRANTED—
Nov 12, 2020EXT3SOU EXTENSION 3 FILED—
Nov 12, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 14, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 12, 2020EX2GSOU EXTENSION 2 GRANTED—
May 12, 2020EXT2SOU EXTENSION 2 FILED—
May 12, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 13, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 11, 2019EX1GSOU EXTENSION 1 GRANTED—
Nov 11, 2019EXT1SOU EXTENSION 1 FILED—
Nov 11, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 14, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 19, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 19, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 27, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 9, 2019ALIEASSIGNED TO LIE—
Jan 24, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 24, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Jan 24, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 24, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 24, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 22, 2019ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jan 15, 2019PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Dec 26, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 17, 2018DOCKASSIGNED TO EXAMINER—
Oct 11, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 6, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance